FP824EFFICACY OF THE NEW DESENSITIZATION PROTOCOL FOR ABO IMCOMPATIBLE LIVING DONOR KIDNEY TRANSPLANTATION USING LOW DOSE RITUXIMAB WITHOUT PLASMAPHERESIS | Zendy

AI Assistant Blog Pricing

FP824EFFICACY OF THE NEW DESENSITIZATION PROTOCOL FOR ABO IMCOMPATIBLE LIVING DONOR KIDNEY TRANSPLANTATION USING LOW DOSE RITUXIMAB WITHOUT PLASMAPHERESIS

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.